Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIb, Prospective, Multicentre, Open-Label Extension Study To Assess Long Term Safety And Effectiveness Of Dysport® Using 2 mL Dilution In Adults With Cervical Dystonia

NCT01753336 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01753336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIb, Prospective, Multicentre, Open-Label Extension Study To Assess Long Term Safety And Effectiveness Of Dysport® Using 2 mL Dilution In Adults With Cervical Dystonia
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
October 31, 2015
Enrollment
112 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia